Fiche publication
Date publication
novembre 2025
Journal
The French journal of urology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr KLEINCLAUSS François
Tous les auteurs :
Drouin SJ, Goujon A, Defortescu G, Frontczak A, Bessède T, Prudhomme T, Sallusto F, Alezra E, Verhoest G, Soorojebally Y, Ploussard G, Baboudjian M, Bigot P, Khene ZE, Leon P, Roumiguié M, Neuville P, Escoffier A, Delpech PO, Mazancourt ES, Champy C, Branchereau J, Uhl M, Roupret M, Kleinclauss F, Timsit MO, Boissier R, Culty T
Lien Pubmed
Résumé
Potential donors for transplantation are screened for malignancies that can be transmitted on to the recipient. The discovery of cancer or a history of cancer often leads to contraindications for organ donation, while in some cases the cancer transmission risk is very low. The current context of organ shortage leads us to reconsider the use of organs from donors with cancer or a history of cancer when the risk of transmission is minimal or less than the risk of death on the waiting list. The Transplantation Committee (CTAFU) in partnership with the Cancer Committee (CCAFU) of the Association Française d'Urology (AFU) were asked to publish guidelines for clinical practice concerning the use of donors with cancer or a history of urological cancer (prostate cancer, kidney cancer, urothelial tumors, testicular cancer).
Mots clés
Donor selection, Kidney neoplasms, Kidney transplantation, Non-muscle invasive neoplasms, Prostatic neoplasms, Testicular neoplasms, Tissue and organ procurement, Urinary bladder neoplasm
Référence
Fr J Urol. 2025 11;35(11):102960
